ABIOMED Inc. is commencing its pilot clinical trial in the U.S. for the IMPELLA 2.5 minimally invasive ventricular ...

A 1064 nm wavelength laser technology, the Atrilaze Surgical Ablation system complements its existing 810 nm technology. The system is indicated for delivery of laser light to soft tissue, including cardiac tissue, during surgical procedures. Indications include the incision, excision, dissection, vaporization, ablation or coagulation of soft tissue.

According to its recently granted U.S. patent, shorter scanning time and clinically diagnostic images may be obtained with UltraSPECT Wide Beam Reconstruction (WBR) technology, a new resolution recovery reconstruction method.

The Elecsys proBNP assay is the first and only natriuretic peptide test to receive FDA clearance for the risk assessment of cardiac events in people who have stable coronary artery disease — nearly 13 million in the U.S.

Impella Recover technology, which includes the Recover LP 2.5, LD, LP 5.0 and the RD, are commercially available in ...

Changing the entire paradigm of ECG management from the “data island” concept to the complete longitudinal patient ...

The Concerto/Virtuoso line of implantable cardiac devices reportedly consists of cardiac rhythm disease management products that allow for automatic, wireless remote data transmission from a heart failure patient’s device to the doctor’s office.